StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
BDSX

Biodesix, Inc.

BDSX Nasdaq Services-Medical Laboratories EDGAR ↗
$22.03
+0.69 +3.26%

Key statistics

from XBRL data in SEC filings
Market cap
$223M
Revenue (TTM)
$96.1M
Net income (TTM)
-$32.0M
EPS (TTM)
$-3.96
P/E ratio
Dividend yield
Free cash flow
-$23.5M
Cash
$25.6M
Total assets
$94.6M
Gross margin
52-week range
$5.26 – $24.92

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Shareholder vote results May 20, 2026 10-Q Quarter ended 2026-03-31 May 4, 2026 8-K Results of operations (earnings release) May 4, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 26, 2026 8-K/A Results of operations (earnings release) Jan 12, 2026 10-Q Quarter ended 2025-09-30 Nov 3, 2025 8-K Results of operations (earnings release) Nov 3, 2025 8-K Other events Oct 1, 2025 8-K Modified rights of security holders; Amended charter or bylaws Sep 15, 2025 8-K Other events Sep 11, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Shareholder vote results May 21, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Results of operations (earnings release) May 13, 2025 8-K Director or officer change Apr 17, 2025 8-K Delisting notice or listing-rule failure Mar 28, 2025 10-K Fiscal year ended 2024-12-31 Mar 3, 2025 8-K Results of operations (earnings release) Mar 3, 2025 8-K Results of operations (earnings release) Jan 10, 2025 10-Q Quarter ended 2024-09-30 Nov 1, 2024 8-K Results of operations (earnings release) Nov 1, 2024 8-K Regulation FD disclosure Aug 15, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024 8-K Results of operations (earnings release) Aug 7, 2024 8-K Shareholder vote results May 23, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024 8-K Results of operations (earnings release) May 8, 2024 8-K Entered a material agreement; Unregistered sale of equity; Amended charter or bylaws; Other events Apr 9, 2024 10-K Fiscal year ended 2023-12-31 Mar 1, 2024 8-K Results of operations (earnings release) Mar 1, 2024 8-K Took on a direct financial obligation Dec 20, 2023 10-Q Quarter ended 2023-09-30 Nov 7, 2023 8-K Results of operations (earnings release) Nov 7, 2023 10-Q Quarter ended 2023-06-30 Aug 7, 2023 8-K Results of operations (earnings release) Aug 7, 2023 8-K Other events Jul 26, 2023 8-K Director or officer change Jun 6, 2023 8-K Shareholder vote results May 25, 2023